Assessment Report for Multaq, “Evaluation of Medicines for Human Use,” European Medicines Agency, Procedure No. EMEA/H/C/001043, 2009. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/001043/WC500044538.pdf
 S. B. Bari, B. R. Kadam, Y. S. Jaiswal and A. A. Shirkhedkar, “Impurity Profile: Significance in Active Pharmaceutical Ingredient,” Eurasian Journal of Analytical Chemistry, Vol. 2, No. 1, 2007, pp. 177-189.
 C. Xie, S. L. Yang, D. F. Zhong, X. J. Dai and X. Y. Chen, “Simultaneous Determination of Dronedarone and Its Active Metabolite Debutyldronedarone in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study,” Journal of Chromatography B, Vol. 879, No. 28, 2011, pp. 3071-3075.
 D. Patel and A. Choudhury, “Development and Validation of Dronedarone HCl In Plasma by RP-HPLC Method Coupled with UV-Detector,” Inventi Impact: Biomedical Analysis, Vol. 2012, 2012, Article ID: Inventi:pba/47/12. http://www.inventi.in/Article/pba/47/12.aspx
 N. Tondepu1, S. S. Sait, K. V. Surendranath, R. K. Kaja1 and S. Kumar, “A Stability Indicating HPLC Method for Dronedarone in Bulk Drugs and Pharmaceutical Dosage Forms,” American Journal of Analytical Chemistry, Vol. 3, 2012, pp. 544-551. doi:10.4236/ajac.2012.38072
 A. Patel and J. Akhtar, “RP-HPLC Method Development and Validation of Dronedarone HCl in Its Pure Form and Tablet Dosage Form,” Journal of Chemical and Pharmaceutical Research, Vol. 4, No. 4, 2012, pp. 2173-2179.
 B. Dabhi, Y. Jadeja, M. Patel, H. Jebaliya, D. Karia and A. Shah, “Method Development and Validation of Stability- Indicating RP-HPLC Method for Quantitative Analysis of Dronedarone Hydrochloride in Pharmaceutical Tablets,” Scientific Pharmacology, in press, pp. 1209-1215.
 A. C. Mali, S. S. Ippar, M. S. Bodke, N. S. Patil and V. T. Mathad, “An Improved, and Efficient Process for the Production of Dronedarone Hydrochloride, an Antiarrhythmic Drug,” Organic Process Research & Development, Vol. 17, No. 5, 2013, pp. 863-868.